Efforts to stem the spread of coronavirus are being made in the US private aviation industry in the form of antimicrobial shielding.
American aviation service provider, Constant Aviation, is currently working on a contract to treat business and private aircraft with MicroShield 360, an FDA-approved antimicrobial shield.
The company has treated the interior cabins of around 250 aircraft since March 9th, with that number expected to double by the end of the month. Application crews are now present at more than 150 airports nationwide, and technicians have streamlined the process to less than two hours even on aircraft with large passenger cabins.
According to Constant Aviation CEO, David Davies, operators are urgently having to treat their aircraft to help protect passengers, crews and maintenance technicians from bacteria and germs.
“Our objective in expanding the applicator network to airports nationwide is to make it as convenient and efficient as possible for aircraft to be treated,” he says.
MicroShield 360 is an antimicrobial coating system that is claimed to kill 99.99% of bacteria. It has been tested for effectiveness and durability, ensuring that treated surfaces are reducing germs constantly. The coating is clear, colourless, odourless, non-toxic and hypoallergenic and safe for humans and animals.
Each MicroShield 360 application consists of a three-step process: First, an electrostatic disinfectant is applied to all surfaces. Then a second, specially formulated disinfectant is applied. Finally, a proprietary coating imparts a biostatic finish to treated surfaces, preventing pathogens from living on them even after the initial application.
Since it constantly reduces microbial contamination of bacteria, viruses, mould, algae, yeast, mildew, fungi and odours, the MicroShield 360 coating can play an important role in helping to protect passengers and crew from a wide range of illnesses caused by viral contamination.